Abnormal fibre usage in UC in remission

Conclusions
Gut fermentation of NSP and starch is diminished in patients with UC. This cannot be explained by abnormal gut transit and was not corrected by increasing RS/WB intake, and may be due to abnormal functioning of the gut microbiota.

Trial registration number
Australian New Zealand Clinical Trials Registry: ACTRN12614000271606.

Source: Gut - March 6, 2015 Category: Gastroenterology Authors: James, S. L., Christophersen, C. T., Bird, A. R., Conlon, M. A., Rosella, O., Gibson, P. R., Muir, J. G. Tags: Inflammatory bowel disease Source Type: research